These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8053238)

  • 1. [Pathophysiology and pathobiochemistry of restenosis].
    Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A
    Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
    Hombach V; Waltenberger J; Voisard R; Höher M
    Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of smooth muscle cell proliferation after balloon angioplasty].
    Hanke H; Karsch KR
    Herz; 1992 Oct; 17(5):300-8. PubMed ID: 1473814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of re-stenosis after angioplasty].
    Bauriedel G; Kandolf R; Welsch U; Höfling B
    Z Kardiol; 1994; 83 Suppl 4():31-41. PubMed ID: 7856278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellularity and ultrastructural characteristics of human atherectomy specimens: comparison between restenosis and primary stenotic tissue of coronary and peripheral lesions].
    Bauriedel G; Höfling B; Grünwaldt C; Beinert T; Welsch U
    Z Kardiol; 1993 Aug; 82(8):485-93. PubMed ID: 8212782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of smooth muscle cell proliferation and its possible role in preventing restenosis post-angioplasty.
    Nikol S; Höfling B
    Wien Klin Wochenschr; 1995; 107(13):379-89. PubMed ID: 7638968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug and instrumental therapeutic approaches for prevention of restenosis].
    Höfling B; Huehns TY; Gonschior P; Nikol S
    Z Kardiol; 1995; 84 Suppl 4():151-8. PubMed ID: 8585268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty.
    Matsuura R; Isaka N; Imanaka-Yoshida K; Yoshida T; Sakakura T; Nakano T
    J Pathol; 1996 Nov; 180(3):311-6. PubMed ID: 8958811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Local drug administration systems, preclinical and clinical use: perspectives and limitations].
    Gonschior P; Wilensky R; March K; Höfling B
    Z Kardiol; 1996 Mar; 85(3):155-65. PubMed ID: 8659193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro balloon treatment of coronary plaque material of the human: effect of dilation time on proliferation of smooth muscle cells].
    Voisard R; Dartsch PC; Seitzer U; Grupp C; Hannekum A; Kochs M; Hombach V
    Vasa Suppl; 1991; 33():138-9. PubMed ID: 1788646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The three processes leading to post PTCA restenosis: dependence on the lesion substrate.
    Fuster V; Falk E; Fallon JT; Badimon L; Chesebro JH; Badimon JJ
    Thromb Haemost; 1995 Jul; 74(1):552-9. PubMed ID: 8578523
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin A: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention?
    Gidlöf AC; Ocaya P; Krivospitskaya O; Sirsjö A
    Clin Sci (Lond); 2008 Jan; 114(1):19-25. PubMed ID: 18047466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vessel wall reaction in restenosis.
    Schwartz RS
    Semin Interv Cardiol; 1997 Jun; 2(2):83-8. PubMed ID: 9546996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of restenosis. A correlation of clinical observations with cellular responses.
    Haudenschild CC
    Z Kardiol; 1990; 79 Suppl 3():17-22. PubMed ID: 2099039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased expression of growth factors following angioplasty. Restenosis by stimulation of vascular smooth muscle cells].
    Bauriedel G
    Fortschr Med; 1992 Apr; 110(11):196. PubMed ID: 1601359
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormone therapy as a therapeutic option in prevention of restenosis after angioplasty? Analysis of estrogen and progesterone receptors in human coronary plaque cells in vitro].
    Voisard R; Seitzer U; Hannekum A; Kochs M; Hombach V; Böhm W
    Vasa Suppl; 1992; 35():130-1. PubMed ID: 1481016
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiological insights from studies of retrieved coronary atherectomy tissue.
    Glover C; O'Brien ER
    Semin Interv Cardiol; 2000 Dec; 5(4):167-73. PubMed ID: 11176010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary irradiation for the prevention of restenosis.
    Weinberger J; Simon AD
    Curr Opin Cardiol; 1997 Sep; 12(5):468-74. PubMed ID: 9352174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.